Please assess the completion status of the following clinical trial:

Trial Title: Generation of Powerful Biological Tools for Understanding the Pathophysiology of Chronic Granulomatous Disease.

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* diagnostic of chronic granulomatous disease (CGD) with determined genetic form~* for minors, patient requiring installation or removal of deep venous general anesthesia.~Exclusion Criteria:~* patients with acute infections scalable to practice of skin biopsy under local anesthesia~* patient with impaired hemostasis acquired (drug) or innate.

- Gender: ALL
- Minimum Age: 6 Months
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Chronic Granulomatous Disease (Type: EXPERIMENTAL): Sample collection were performed from patients with chronic granulomatous disease linked to X or due to Autosomal Recessive (AR) forms AR220, AR470 and AR670.

Based on this trial design, predict the completion outcome and termination type (if applicable).